Symbol | Exchange | Currency |
|---|
Acadia Pharmaceuticals (ACAD) announces that its late-stage trial testing pimavanserin in patients with dementia-related psychosis (((DRP)) met the trial's primary endpoint.The...
Jefferies (NYSE:JEF) analyst Linda Tsai maintained a Buy rating on Acadia Realty (NYSE:AKR) Trust on Thursday, setting a price target of $26, which is approximately 16.85% above...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Sell | Sell | Neutral |
| Technical Indicators | Strong Buy | Sell | Sell | Neutral | Strong Buy |
| Summary | Strong Buy | Neutral | Sell | Neutral | Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 2,735.10 | 2,765.00 | 2,706.70 | +97.1 | +3.68% | 2.71M | NASDAQ | |||
| 372.84 | 377.54 | 367.00 | +5.03 | +1.37% | 11.71M | NASDAQ | |||
| 68.72 | 68.85 | 67.01 | +1.23 | +1.82% | 4.03M | NYSE | |||
| 43.42 | 43.45 | 42.26 | +1.32 | +3.14% | 25.07M | NYSE | |||
| 194.50 | 196.40 | 189.76 | +8.43 | +4.53% | 21.69M | NYSE | |||
| 27.43 | 27.66 | 26.56 | +1.44 | +5.54% | 6.19M | NASDAQ | |||
| 437.14 | 444.66 | 432.87 | -30.36 | -6.49% | 1.06M | NYSE | |||
| 92.20 | 92.77 | 85.27 | +12.67 | +15.93% | 15.46M | NASDAQ | |||
| 53.43 | 53.92 | 52.94 | +0.25 | +0.47% | 14.61M | NASDAQ | |||
| 38.82 | 39.33 | 36.08 | +0.81 | +2.13% | 46.18M | NYSE | |||
| 75.68 | 75.90 | 74.39 | +1.46 | +1.97% | 7.36M | NASDAQ | |||
| 301.02 | 302.39 | 296.98 | +0.54 | +0.18% | 2.64M | NASDAQ | |||
| 15.95 | 16.18 | 14.02 | +3.22 | +25.29% | 82.38M | NASDAQ | |||
| 41.51 | 41.87 | 39.80 | +2.15 | +5.46% | 41.73M | NYSE | |||
| 6.225 | 6.24 | 6.11 | +0.075 | +1.22% | 5.43M | NYSE |
Acadia Realty Trust is an equity real estate investment trust focused on delivering long-term, profitable growth via its dual – Core Portfolio and Fund – operating platforms and its disciplined, location-driven investment strategy. Acadia Realty Trust is accomplishing this goal by building a best-in-class core real estate portfolio with meaningful concentrations of assets in the nation’s most dynamic corridors; making profitable opportunistic and value-add investments through its series of discretionary, institutional funds; and maintaining a strong balance sheet.
